NCT01200108View on ClinicalTrials.gov

AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions

Asthma

Interventions

DRUG

Budesonide

DRUG

Budesonide

DRUG

Budesonide

Trial Locations (24)

10717

Berlin

15562

Rüdersdorf

21029

Vinnytsia

35037

Marburg

49074

Dnipropetrovsk

53119

Bonn

53123

Bonn

60318

Peter, Kardos, MD, Frankfurt

61124

Kharkiv

63110

Rodgau-Dudenhofen

64287

Darmstadt

68723

Schwetzingen

76018

Ivano-Frankivsk

80331

München

83099

Donetsk

40-752

Katowice

31-159

Krakow

92-215

Lódz

20-954

Lublin

60-214

Poznán

96-100

Skierniewice

02-097

Warsaw

50-239

Wroclaw

03680

Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Activaero GmbH

INDUSTRY

NCT01200108 - AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma | Biotech Hunter | Biotech Hunter